Study Stopped
Study terminated by Sponsor following a recommendation from external DMC based on lack of emerging benefit; there were no new emergent safety findings
A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
A Phase 3, Long-term Active Treatment Extension Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
1 other identifier
interventional
310
29 countries
221
Brief Summary
The purpose of this study is to assess long-term safety data of GED-0301 for a period of up to 208 weeks in adult subjects (i.e., ≥ 18 years of age) who participated in the core Phase 3 GED-0301-CD-002 and GED-0301-CD-003 studies and adolescent subjects (i.e., 12 to 17 years of age) who participated in the core Phase 3 GED-0301-CD-003 study. Although all subjects will receive active treatment, this study is double-blinded for the entire 208 weeks for the purpose of preserving the blind of the subject's treatment allocation in the initial, core Phase 3 GED-0301 study. The GED-0301-CD-003 trial was not initiated; see detailed description.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Jul 2016
221 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2015
CompletedFirst Posted
Study publicly available on registry
December 29, 2015
CompletedStudy Start
First participant enrolled
July 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 4, 2018
CompletedResults Posted
Study results publicly available
January 29, 2019
CompletedJanuary 29, 2019
January 1, 2019
1.4 years
December 23, 2015
January 8, 2019
January 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Treatment Emergent Adverse Events From Week 0 to Week 208
A TEAE was defined as any adverse event (AE) occurring or worsening on or after the first treatment of GED-0301 and up to 28 days after the last GED- 0301 dose or the last follow-up date, whichever occurred earlier. A serious AE = any AE which results in death; is life-threatening; requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability/incapacity; is a congenital anomaly/birth defect; constitutes an important medical event. The severity of AEs was assessed by the investigator and based on the following scale; Mild = asymptomatic or mild symptoms; clinical or diagnostic observations only; Moderate = Symptoms cause moderate discomfort; Severe (could be non-serious or serious) = symptoms causing severe discomfort/pain.
From the first day of GED-0301 until 28 days after the last dose of IP; maximum treatment duration was 16.1 weeks in the GED-0301 40 mg Alt dose; 16.3 weeks in the GED 40 mg continuous dose and 56.1 weeks in the GED-0301 160 mg Alt dose
Study Arms (5)
GED-0301 (160 mg) followed by Placebo intermittent 160 mg
EXPERIMENTALGED-0301 160 mg once daily (QD) for 12 weeks, followed by alternating Placebo (PBO) QD for 4 weeks with GED 0301 160 mg QD for 4 weeks, up to 208 weeks, if the subject previously received Placebo in the prior GED-0301 Study
Intermittent GED-0301 160 mg and placebo
EXPERIMENTALAlternating GED-0301 160 mg once daily (QD) for 4 weeks with placebo (PBO) QD for 4 weeks, up to 208 weeks, depending on previous response in the prior GED-0301 study
Intermittent placebo and GED-0301 40 mg
EXPERIMENTALAlternating PBO once daily (QD) for 4 weeks with GED-0301 40 mg QD for 4 weeks with, up to 208 weeks, depending on previous response in the prior GED-0301 study
Continuous GED-0301 40 mg
EXPERIMENTALGED-0301 40 mg once daily (QD) for up to 208 weeks
Intermittent placebo and GED-0301 160 mg
EXPERIMENTALAlternating PBO QD for 4 weeks with GED-0301 160 mg QD for 4 weeks, through Week 208
Interventions
Mongersen
Placebo
Eligibility Criteria
You may qualify if:
- Subjects must satisfy the following criteria to be screened and enrolled in the study:
- Male or female ≥ 18 years of age.
- Subject must have participated in the GED-0301-CD-002 or GED 0301 CD 003 study.
- Subject must use protocol approved contraception.
- Adolescent subjects must satisfy the following criteria to be screened and enrolled in the study
- Male or female 12 to 17 years of age.
- Subject must have participated in the GED 0301 CD 003 study.
- Subject is able to swallow the IP tablets.
- Subject must use protocol approved contraception.
You may not qualify if:
- The presence of any of the following will exclude a subject from screening and enrollment:
- Subject had experienced a serious adverse event (SAE) related to the investigational product while participating in the previous Phase 3 GED-0301 study.
- Subject has initiated biologic agents, such as TNF-α blockers or integrin antagonists.
- Subject is pregnant or breastfeeding.
- Subject has developed a known hypersensitivity to oligonucleotides, GED 0301 or any ingredient in the investigational product.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Celgenelead
Study Sites (231)
Medical Associates Research Group Inc.
San Diego, California, 902123, United States
Atlanta Gastroenterology Associates, LLC
Atlanta, Georgia, 30342, United States
Indiana University
Indianapolis, Indiana, 46202, United States
Health Science Research Center, LLC
Pratt, Kansas, 67124, United States
Via Christi Research a division of Via Christi Hospitals Wichita Inc
Wichita, Kansas, 67208, United States
Gastroenterology Associates LLC
Baton Rouge, Louisiana, 70809, United States
Metropolitan Gastroenterology
Chevy Chase, Maryland, 20815, United States
Clinical Research Institute of Michigan, LLC
Chesterfield, Michigan, 48047, United States
Gastroenterology Associates of Western Michigan PLC
Wyoming, Michigan, 49519, United States
Ehrhardt Clinical Research LLC
Belton, Missouri, 64012, United States
Columbia University Medical Center
New York, New York, 10032, United States
Trial Management Associates LLC
Wilmington, North Carolina, 28401, United States
ClinSearch LLC
Chattanooga, Tennessee, 37421, United States
Texas Clinical Research Institute LLC
Arlington, Texas, 76012, United States
Texas Digestive Disease Consultants - Dallas
Dallas, Texas, 75231, United States
Texas Digestive Disease Consultants - Southlake
Flower Mound, Texas, 75028, United States
University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Sagact Pllc
San Antonio, Texas, 78229, United States
San Antonio Military Medical Center
San Antonio, Texas, 78229, United States
Digestive Health Specialists of Tyler
Tyler, Texas, 75701, United States
Virginia Mason Medical Center
Seattle, Washington, 98101, United States
University of Washington School of Medicine
Seattle, Washington, 98104, United States
The Vancouver Clinic
Vancouver, Washington, 98664-4896, United States
Concord Repatriation General Hospital
Concord, New South Wales, 2139, Australia
Centre For Digestive Diseases
Five Dock, New South Wales, 2046, Australia
Liverpool Hospital
Liverpool, New South Wales, 2170, Australia
Mater Adult Hospital
South Brisbane, Queensland, 4101, Australia
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
Box Hill Hospital
Box Hill, Victoria, 3128, Australia
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
Monash Medical Centre Clayton
Bentleigh East, 3165, Australia
LKH Universitaetsklinikum Graz
Graz, 8036, Austria
Medizinische Universitat Innsbruck
Innsbruck, 6020, Austria
KH der Barmherzigen Bruder Linz
Linz, 4021, Austria
LKH - Universitätsklinikum der PMU Salzburg
Salzburg, 5020, Austria
KH der Barmherzigen Brüder St.Veit an der Glan
Sankt Veit an der Glan, 9300, Austria
Krankenanstalt Rudolfstiftung Wien
Wein, 1030, Austria
AKH Medizinische Universitat Wien
Wein, 1090, Austria
Universitair Ziekenhuis Brussel
Brussels, 1090, Belgium
UZ Leuven
Leuven, 3000, Belgium
CHU Sart Tilman
Liège, 4000, Belgium
MHAT Kaspela EOOD
Plovdiv, 4002, Bulgaria
MHAT Ruse AD
Rousse, 7002, Bulgaria
Second MHAT Sofia AD
Sofia, 1202, Bulgaria
City Clinic UMHAC EOOD
Sofia, 1407, Bulgaria
UMHAT Sv Ivan Rilski EAD
Sofia, 1431, Bulgaria
UMHAT Tsaritsa Yoanna - ISUL EAD
Sofia, 1527, Bulgaria
MHAT Doverie AD
Sofia, 1632, Bulgaria
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
University of Alberta
Edmonton, Alberta, T6G 2X8, Canada
South Edmonton Gastroenterology
Edmonton, Alberta, T6L 6K3, Canada
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9, Canada
GI Research Institute
Vancouver, British Columbia, V6Z 2K5, Canada
PerCuro Clinical Research
Victoria, British Columbia, V8V 3P9, Canada
Brandon Medical Arts Clinic
Brandon, Manitoba, R7A 0N7, Canada
McMaster University Health Sciences Center
Hamilton, Ontario, L8N 3Z5, Canada
London Health Science Center U. Hospital
London, Ontario, N6A 5A5, Canada
LHSC Victoria Hospital
London, Ontario, N6A 5W9, Canada
Montfort Hospital
Ottawa, Ontario, K1K 0T2, Canada
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
Toronto Digestive Disease Associates Inc
Vaughan, Ontario, L4L 4Y7, Canada
Medicine Professional Corporation
Waterloo, Ontario, N2J 1C4, Canada
Centre de sante et de services sociaux Champlain Charles Le Moyne
Greenfield Park, Quebec, J4V 2H1, Canada
McGill University Health Centre Glen Site Royal Victoria Hospital
Montreal, Quebec, H4A 3J1, Canada
Clinical Hospital Centre Osijek
Osijek, 31000, Croatia
Fakultni nemocnice u sv Anny v Brne
Brno, 656 91, Czechia
Hepato-Gastroenterologie HK
Hradec Králové, 50012, Czechia
PreventaMed
Olomouc, 77900, Czechia
CCBR Prague CZ
Prague, 13000, Czechia
Aarhus Universitetshospital
Aahus C, 8000, Denmark
Alborg Universitets Hospital
Aalborg, 9000, Denmark
Nordsjaellands Hospital Frederikssund
Frederikssund, 3600, Denmark
Herlev Hospital
Herlev, 2730, Denmark
Koge Sygehus
Køge, 4600, Denmark
Regionshospitalet Silkeborg
Silkeborg, 8600, Denmark
CHU Amiens Hopital Sud
Amiens, 80054, France
CHU Besancon Hopital Jean Minjoz
Besançon, 25030, France
CHU Tours Hopital Trousseau
Chambray-lès-Tours, 37170, France
CHU Clermont Ferrand
Clermont-Ferrand, 63000, France
Hopital Beaujon
Clichy, 92110, France
CHU Nantes Hotel Dieu
Nantes, 44093, France
CHU Nice Hopital de lArchet 2
Nice, 06200, France
Groupe Hospitalier Sud Hopital Haut Leveque USN
Pessac, 33604, France
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
CHU Reims Hopital Robert Debre
Reims, 51092, France
CHU Rennes Hopital Pontchaillou
Rennes, 35033, France
CHU Saint Etienne Hopital Nord
Saint-Etienne, 42055, France
CHU Strasbourg Hopital Hautepierre
Strasbourg, 67098, France
CHU de Toulouse Hopital Rangueil
Toulouse, 31059, France
Hopital de Brabois Adultes
Vandœuvre-lès-Nancy, 54511, France
Charite Universitaetsmedizin Berlin Campus Benjamin Franklin
Berlin, 12200, Germany
DRK Kliniken Berlin Westend
Berlin, 14050, Germany
Krankenhaus Waldfriede e V
Berlin, 14163, Germany
Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH
Bochum, 44789, Germany
Universitaetsklinikum Carl Gustav Carus TU Dresden
Dresden, 01307, Germany
Universitaetsklinikum Erlangen
Erlangen, 91054, Germany
Kliniken Essen-Mitte
Essen, 45136, Germany
Agaplesion Markus Krankenhaus
Frankfurt, 60431, Germany
Universitaetsklinikum Halle Saale
Halle, 06120, Germany
Asklepios Klinik Hamburg
Hamburg, 22559, Germany
Medizinische Hochschule Hannover
Hanover, 30625, Germany
Universitaetsklinikum Heidelberg
Heidelberg, 69120, Germany
Praxis fuer Gastroenterologie Dr Ehehal Dr Helmstaedter
Heidelberg, 69121, Germany
Universitaetsklinikum Jena
Jena, 07740, Germany
Universitaetsklinikum Schleswig Holstein Campus Kiel
Kiel, 24105, Germany
University Leipzig
Leipzig, 04103, Germany
EUGASTRO GmbH
Leipzig, 4103, Germany
Medizinisches Zentrum Klinikum Lueneburg
Lüneburg, 21339, Germany
Klinikum Mannheim GmbH Universitaetsklinikum
Mannheim, 68167, Germany
Klinikum der Universitaet Muenchen
München, 81377, Germany
Gastro Campus Research
Münster, 48159, Germany
Staedtisches Klinikum Braunschweig gGmbH Standort Salzdahlumer
Niedersachsen, 38126, Germany
Universitaetsklinikum Regensburg
Regensburg, 93053, Germany
Universitaetsklinikum Ulm
Ulm, 89081, Germany
University General Hospital of Alexandroupolis
Alexandroupoli, 68100, Greece
General Hospital of Athens Evangelismos
Athens, 10676, Greece
Athens Medical Center
Athens, 15125, Greece
University General Hospital of Patras
Rio Patras, 26500, Greece
DRC Gyogyszervizsgalo Kozpont Kft
Balatonfüred, 8230, Hungary
Magyar Honvedseg Egeszsegugyi Kozpont
Budapest, 1062, Hungary
Semmelweis Egyetem AOK
Budapest, 1088, Hungary
Endomedix Diagnosztikai Kozpont
Budapest, 1139, Hungary
Debreceni Egyetem Klinikai Kozpont
Debrecen, 4032, Hungary
Szent Pantaleon Korhaz Rendelointezet Dunaujvaros
Dunaújváros, 2400, Hungary
Petz Aladar Megyei Oktato Korhaz
Győr, 9024, Hungary
Clinfan Szolgaltato Kft
Szekszárd, 7100, Hungary
HaEmek Medical Center
Afula, 18341, Israel
Soroka University Medical Center
Beersheba, 84101, Israel
Rambam Health Care Campus
Haifa, 3109601, Israel
Shaare Zedek Medical Center
Jerusalem, 91031, Israel
Hadassah University Hospital
Jerusalem, 9112001, Israel
Rabin Medical Center
Petah Tikva, 49100, Israel
Chaim Sheba Medical Center
Ramat Gan, 52621, Israel
Kaplan Medical Center
Rehovot, 76100, Israel
Tel Aviv Sourasky Medical Center Department of Hematology
Tel Aviv, 64239, Israel
The Baruch Padeh MC, Poriya
Tiberias, 1520800, Israel
Assaf Harofeh Medical Center
Ẕerifin, 70300, Israel
Azienda Ospedaliera Universitaria Policlinico Sant Orsola Malpighi
Bologna, 40138, Italy
Azienda Ospedaliera Universitaria Policlinico G Martino
Messina, 98125, Italy
Fondazione IRCCS CA Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
Azienda Ospedaliera Vincenzo Cervello
Palermo, 90146, Italy
Fondazione IRCCS Policlinico San Matteo
Pavia, 27100, Italy
Universita Campus Bio Medico di Roma
Roma, 00128, Italy
Policlinico Universitario Agostino Gemelli
Roma, 00168, Italy
Azienda Ospedaliera San Camillo Forlanini
Rome, 00152, Italy
Azienda Ospedaliera Universitaria Policlinico Tor Vergata
Rome, 133, Italy
Istituto Clinico Humanitas
Rozzano (MI), 20089, Italy
IRCCS Policlinico San Donato
San Donato Milanese, 20097, Italy
IRCCS Ospedale Casa Sollievo della Sofferenza
San Giovanni Rotondo FG, 71013, Italy
Digestive Diseases Center Gastro
Riga, LV-1006, Latvia
Pauls Stradins Clinical University Hospital
Riga, LV1002, Latvia
VU Medisch Centrum
Amsterdam, 1081 HV, Netherlands
Academisch Medisch Centrum
Amsterdam, 1105, Netherlands
Amphia Ziekenhuis
Breda, 4819 EV, Netherlands
Radboudumc
Nijmegen, 6525 GA, Netherlands
Zuyderland Medisch Centrum
Sittard-Geleen, 6162 BG, Netherlands
St. Elisabeth Ziekenhuis
Tilburg, 5022 GC, Netherlands
Akershus universitetssykehus HF
Lørenskog, 1478, Norway
Oslo Universitetssykehus Rikshospitalet
Oslo, N-0027, Norway
Niepubliczny Zaklad Opieki Zdrowotnej POLIMEDICA
Kielce, 25-364, Poland
Indywidualna Praktyka Lekarska Maciej Zymla
Knurów, 44-190, Poland
SPZOZ Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej - Centralny Szpital Weteranow
Lodz, 90-647, Poland
Centrum Medyczne Medyk
Rzeszów, 35-055, Poland
Endoskopia Sp. z o.o.
Sopot, 81-756, Poland
Hospital de Braga
Braga, 4710-243, Portugal
Hospital da Senhora da Oliveira Guimaraes
Guimarães, 4835-044, Portugal
S.C MedLife S.A
Bucharest, 010719, Romania
CMI Dr. Tirnaveanu Amelita
Oradea, 410066, Romania
Centrul de Gastroenterologie Dr. Goldis
Timișoara, 300002, Romania
TSBIH Territorial Clinical Hospital
Krasnoyarsk, 660022, Russia
SBHI of NN region RCH of NN n.a. N.A.Semashko
Nizhny Novgorod, 603126, Russia
SBEIHPE Novosibirsk State Medical University
Novosibirsk, 630054, Russia
FSBI Scientific Research Institute of Physyology and Basic Medicine under the SB of RAMS
Novosibirsk, 630117, Russia
Evromedservis
Pushkin, 196603, Russia
SEIHPE Rostov State Medical University of MoH of RF
Rostov-on-Don, 344022, Russia
SPb SBIH City Hospital # 26
Saint Petersburg, 196247, Russia
NonState Healthcare Institution Central Clinical Hospital, Samara station JSC Russian Railways
Samara, 443041, Russia
Clinical Center Zvezdara
Belgrade, 11000, Serbia
Military Medical Academy
Belgrade, 11000, Serbia
Clinical Center Bezanijska Kosa
Belgrade, 11080, Serbia
Fakultna nemocnica s poliklinikou F. D. Roosevelta
Banská Bystrica, 975 17, Slovakia
Alian s.r.o.
Bardejov, 08501, Slovakia
Gastroeneterologicka ambulancia MUDr. Peter Hegyi s.r.o.
Malacky, 90122, Slovakia
Fakultna nemocnica Nitra
Nitra, 949 01, Slovakia
KM Management, spol. s r.o.
Nitra, 94901, Slovakia
GASTRO I., s.r.o.
Prešov, 080 01, Slovakia
Dong-A University Hospital
Busan, 49201, South Korea
Pusan National University Hospital
Busan, 49241, South Korea
Yeungnam University Medical Center
Daegu, 42415, South Korea
Hanyang University Guri Hospital
Guri-si, 11923, South Korea
CHA Bundang Medical Center CHA University
Seongnam-si, 13496, South Korea
Seoul National University Bundang Hospital
Seongnam-si, 13620, South Korea
Kyung Hee University Hospital
Seoul, 02447, South Korea
Kangbuk Samsung Hospital
Seoul, 03181, South Korea
Severance Hospital, Yonsei University Health System
Seoul, 120-752, South Korea
Samsung Medical Center
Seoul, 135-710, South Korea
Hospital del Mar
Barcelona, 08003, Spain
Hospital Clinic I Provincial de Barcelona
Barcelona, 08036, Spain
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, 28222, Spain
Corporacion Sanitaria Parc Tauli
Sabadell, 08208, Spain
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
Danderyds Sjukhus AB
Stockholm, 18288, Sweden
Crohn-Colitis Zentrum Bern Gemeinschaftspraxis Balsiger Seibold und Partner
Bern, 3012, Switzerland
Ankara University Medical Faculty
Ankara, 06100, Turkey (Türkiye)
Yeditepe University Medical School Hospital
Istanbul, 31755, Turkey (Türkiye)
Istanbul University Cerrahpasa Medical Faculty Hospital
Istanbul, 34098, Turkey (Türkiye)
Acibadem Fulya Hospital
Istanbul, 34349, Turkey (Türkiye)
Haydarpasa Numune Training and Research Hospital
Istanbul, 34668, Turkey (Türkiye)
Istanbul Medeniyet Uni Goztepe Training&Res Hosp
Istanbul, 34854, Turkey (Türkiye)
Marmara University Pendik Training and Research Hospital
Istanbul, 34899, Turkey (Türkiye)
Ege University Medical Faculty
Izmir, 35100, Turkey (Türkiye)
Kocaeli Derince Training and Research Hospital
Kocaeli, 41380, Turkey (Türkiye)
RCI Chernivtsi Regional Clinical Hospital Dept of Surgery Bukovinian SMU
Chernivtsi, 58001, Ukraine
CI of PH Kharkiv CCH #2
Kharkiv, 61037, Ukraine
Treatment-Diagnostic Center of Private Enterprise of PMF Atsynus
Kirovohrad, 25006, Ukraine
Ukrainian-German Antiulcer Gastroenterological Center BYK-Kyiv LLC
Kyiv, 01030, Ukraine
Kyiv City Clinical Hospital #1
Kyiv, 02091, Ukraine
SI Republican Clinical Hospital of the MOHU Dept of Gastroenterology O.O.Bogomolets NMU
Kyiv, 04053, Ukraine
CI Odesa Regional Clinical Hospital
Odesa, 65025, Ukraine
Ternopil City Communal Emergency Medical Care Hospital
Ternopil, 46000, Ukraine
CI Zaporizhzhia Regional Clinical Hospital of ZRC
Zaporizhzhya, 69600, Ukraine
Royal Devon and Exeter Hospital Wonford
Exeter, EX2 5DW, United Kingdom
Queen Elizabeth University Hospital
Glasgow, G51 4TF, United Kingdom
Glasgow Royal Infirmary
Glasgow, Scotland, G4 OSF UK, United Kingdom
Hull Royal Infirmary
Hull, HU3 2JZ, United Kingdom
Royal London Hospital
London, E1 1BB, United Kingdom
St Marys Hospital
London, W2 1NY, United Kingdom
Manchester Royal Infirmary
Manchester, M13 9WL, United Kingdom
Nottingham University Hospitals Queens Medical Centre
Nottingham, NG7 2UH, United Kingdom
John Radcliffe Hospital
Oxford, OX3 9DU, United Kingdom
Royal Shrewsbury Hospital
Shrewsbury, SY38XQ, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Following a recommendation by the Data Monitoring Committee (DMC), the study was terminated early by Celgene on 19 Oct 2017 due to a lack of emerging benefit; no emergent safety findings were noted.
Results Point of Contact
- Title
- Anne McClain, Senior Manager
- Organization
- Celgene Corporation
Study Officials
- STUDY DIRECTOR
Guillermo Rossiter, MD
Celgene
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2015
First Posted
December 29, 2015
Study Start
July 25, 2016
Primary Completion
January 4, 2018
Study Completion
January 4, 2018
Last Updated
January 29, 2019
Results First Posted
January 29, 2019
Record last verified: 2019-01